The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AKILI INC | COM | 00974B107 | 556 | 245,912 | SH | SOLE | 245,912 | 0 | 0 | ||
NEUROPACE INC | COM | 641288105 | 161 | 42,972 | SH | SOLE | 42,972 | 0 | 0 | ||
SINGULAR GENOMICS SYSTEMS INC | COM | 82933R100 | 3,540 | 1,415,846 | SH | SOLE | 1,415,846 | 0 | 0 |